EDOC vs. XPH
Compare and contrast key facts about Global X Telemedicine & Digital Health ETF (EDOC) and SPDR S&P Pharmaceuticals ETF (XPH).
EDOC and XPH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. EDOC is a passively managed fund by Global X that tracks the performance of the Solactive Telemedicine & Digital Health Index- TR Net. It was launched on Jul 29, 2020. XPH is a passively managed fund by State Street that tracks the performance of the S&P Pharmaceuticals Select Industry Index. It was launched on Jun 19, 2006. Both EDOC and XPH are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
EDOC vs. XPH - Performance Comparison
Loading graphics...
EDOC vs. XPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
EDOC Global X Telemedicine & Digital Health ETF | -18.45% | -0.62% | -2.87% | -12.61% | -29.99% | -14.21% | 23.87% |
XPH SPDR S&P Pharmaceuticals ETF | -3.32% | 31.60% | 4.94% | 2.97% | -9.83% | -10.54% | 20.47% |
Returns By Period
In the year-to-date period, EDOC achieves a -18.45% return, which is significantly lower than XPH's -3.32% return.
EDOC
- 1D
- 2.83%
- 1M
- -10.48%
- YTD
- -18.45%
- 6M
- -25.27%
- 1Y
- -15.69%
- 3Y*
- -12.07%
- 5Y*
- -16.45%
- 10Y*
- —
XPH
- 1D
- 5.32%
- 1M
- -5.56%
- YTD
- -3.32%
- 6M
- 13.19%
- 1Y
- 24.45%
- 3Y*
- 11.04%
- 5Y*
- 2.79%
- 10Y*
- 3.82%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
EDOC vs. XPH - Expense Ratio Comparison
EDOC has a 0.68% expense ratio, which is higher than XPH's 0.35% expense ratio.
Return for Risk
EDOC vs. XPH — Risk / Return Rank
EDOC
XPH
EDOC vs. XPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Telemedicine & Digital Health ETF (EDOC) and SPDR S&P Pharmaceuticals ETF (XPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EDOC | XPH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.64 | 1.00 | -1.64 |
Sortino ratioReturn per unit of downside risk | -0.81 | 1.47 | -2.28 |
Omega ratioGain probability vs. loss probability | 0.91 | 1.19 | -0.28 |
Calmar ratioReturn relative to maximum drawdown | -0.49 | 1.77 | -2.26 |
Martin ratioReturn relative to average drawdown | -1.38 | 5.52 | -6.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| EDOC | XPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.64 | 1.00 | -1.64 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.63 | 0.14 | -0.76 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.17 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.42 | 0.38 | -0.80 |
Correlation
The correlation between EDOC and XPH is 0.63, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
EDOC vs. XPH - Dividend Comparison
EDOC's dividend yield for the trailing twelve months is around 0.40%, less than XPH's 0.69% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EDOC Global X Telemedicine & Digital Health ETF | 0.40% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XPH SPDR S&P Pharmaceuticals ETF | 0.69% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
Drawdowns
EDOC vs. XPH - Drawdown Comparison
The maximum EDOC drawdown since its inception was -65.76%, which is greater than XPH's maximum drawdown of -48.03%. Use the drawdown chart below to compare losses from any high point for EDOC and XPH.
Loading graphics...
Drawdown Indicators
| EDOC | XPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.76% | -48.03% | -17.73% |
Max Drawdown (1Y)Largest decline over 1 year | -30.71% | -13.15% | -17.56% |
Max Drawdown (5Y)Largest decline over 5 years | -61.76% | -31.63% | -30.13% |
Max Drawdown (10Y)Largest decline over 10 years | — | -35.97% | — |
Current DrawdownCurrent decline from peak | -64.79% | -7.29% | -57.50% |
Average DrawdownAverage peak-to-trough decline | -42.40% | -17.37% | -25.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.89% | 5.23% | +5.66% |
Volatility
EDOC vs. XPH - Volatility Comparison
The current volatility for Global X Telemedicine & Digital Health ETF (EDOC) is 7.53%, while SPDR S&P Pharmaceuticals ETF (XPH) has a volatility of 9.49%. This indicates that EDOC experiences smaller price fluctuations and is considered to be less risky than XPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| EDOC | XPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.53% | 9.49% | -1.96% |
Volatility (6M)Calculated over the trailing 6-month period | 16.50% | 16.38% | +0.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.65% | 24.72% | -0.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.35% | 20.56% | +5.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.33% | 22.22% | +4.11% |